Innovative virotherapy for cancer treatment
Ad-O-Lytics develops tailor-made oncolytic viruses for the treatment of cancer at the University Clinic Ulm . The foundation as a biotech spin-off business of Ulm university is planned to be realized in the year 2017.
Our platform technology paves the way to systemic administration of oncolytic viruses via the bloodstream. This solves a major problem of virotherapy so that tumors as well as disseminated metastases can be efficiently reached and destroyed. This technology is well-developed, internationally patented and has won several awards.